Showing results (71-80 of 125) with videos related to
Sort By:
Pageof 13
Statistics in Medicine|July 1, 2022
Bayesian local exchangeability design for phase II basket trialsYilin Liu, Michael Kane, Denise Esserman, et al.Proceedings of the National Academy of Sciences of the United States of America|July 2, 2014
Multiple types of motives don't multiply the motivation of West Point cadetsAmy Wrzesniewski, Barry Schwartz, Xiangyu Cong, et al.Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|November 19, 2011
A randomized, single-blind, postmarketing study of multiple energy levels of high-intensity focused ultrasound for noninvasive body sculptingNowell Solish, Xiaoming Lin, Robert A Axford-Gatley, et al.Statistics in Medicine|September 3, 2020
Two-stage randomized trial design for testing treatment, preference, and self-selection effects for count outcomesYu Shi, Briana Cameron, Xian Gu, et al.Diabetes Care|September 16, 2025
Risk Factors and Consequences of Lapses in Proliferative Diabetic Retinopathy Care in a National CohortSerina S Applebaum, Yanhong Deng, Julia J Fu, et al.Plos One|December 9, 2020
COVID-19 mortality risk assessment: An international multi-center studyDimitris Bertsimas, Galit Lukin, Luca Mingardi, et al.Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|October 31, 2012
OnabotulinumtoxinA: a meta-analysis of duration of effect in the treatment of glabellar linesRichard Glogau, Michael Kane, Frederick Beddingfield, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 24, 2003
Cross-repressive interaction of the Olig2 and Nkx2.2 transcription factors in developing neural tube associated with formation of a specific physical complexTao Sun, Hualing Dong, Lizi Wu, et al.Journal of Drugs in Dermatology : JDD|October 6, 2010
Expanding the use of neurotoxins in facial aesthetics: a consensus panel's assessment and recommendationsMichael Kane, Lisa Donofrio, Benjamin Ascher, et al.Journal of Drugs in Dermatology : JDD|December 30, 2011
Results of a randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of a botulinum toxin type A topical gel for the treatment of moderate-to-severe lateral canthal linesRichard Glogau, Andrew Blitzer, Fredric Brandt, et al.Pageof 13